This creates a cascade of metabolic dysfunction that makes traditional weight management approaches less effective during perimenopause.[2] GLP-1 Receptor Agonists: Mechanisms of Action in Perimenopause GLP-1 receptor agonists work through multiple pathways that are particularly relevant to perimenopausal women: Appetite Regulation and Satiety These medications reduce appetite and food cravings by activating satiety centers in the brain and slowing gastric emptying
Beyond those exclusions, it lists gastrointestinal side effects, dehydration risk, and thyroid concerns in specific populations as considerations
Also, Wegovy must not be given to people with a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2) or medullary thyroid carcinoma (MTC)
Hypersensitivity reactions include anaphylaxis, angioedema, rash, urticaria, cutaneous vasculitis, and exfoliative skin conditions including Stevens-Johnson syndrome [see Warnings and Precautions]
The exact cost may vary depending on your dosage and whether you choose oral or injectable semaglutide, but the starting price is designed to be as accessible as possible